El actual modelo ensayo pancreatic cancer markers dedo índice varonil Sastre
Tumor Markers - CA153/proGRP/CA242/PGI/PGII/Cy211 | Fapon Biotech Inc.
Potential Prognostic Markers for Pancreatic Cancer | Download Table
Pancreatic cancer stem cells – update and future perspectives - Lonardo - 2010 - Molecular Oncology - Wiley Online Library
Frontiers | Epithelial-Mesenchymal Transition and Its Regulation Mechanisms in Pancreatic Cancer | Oncology
Implementing biological markers as a tool to guide clinical care of patients with pancreatic cancer - ScienceDirect
Pancreatic cancer - Wikipedia
Old Dog, New Tricks: Use of CA 19-9 for Early Diagnosis of Pancreatic Cancer - Gastroenterology
Pancreatic Cancer Treatment (Adult) (PDQ®)–Health Professional Version - NCI
Markers of pancreatic cancer: working toward early detection. - Abstract - Europe PMC
Therapeutic Tools in Pancreatic Cancer
Tumor M2-PK: pancreatic cancer
Types of Tumor Markers and Their Uses - Labweeks
Blood levels of adiponectin and IL-1Ra distinguish type 3c from type 2 diabetes: Implications for earlier pancreatic cancer detection in new-onset diabetes - eBioMedicine
Therapeutic Implications of Molecular Subtyping for Pancreatic Cancer
Assessing the performance of methylated DNA markers in blood for detection of pancreatic ductal adenocarcinoma - Mayo Clinic
Cancers | Free Full-Text | Biomarker Panel for the Diagnosis of Pancreatic Ductal Adenocarcinoma | HTML
Pancreatic Cancer (Pancreatic Ductal Adenocarcinoma) - CTA
Pancreatic Cancer Tumor Markers | GeneTex
Pancreatic cancer: yesterday, today and tomorrow | Future Oncology
Pancreatic Cancer Tumor Markers | GeneTex
Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report. | Semantic Scholar
Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early Detection - Gastroenterology
Pancreatic Cancer Tumor Markers | GeneTex
Guidelines for the Use of Tumor Markers in Pancreatic Ductal Adenocarcinoma | Semantic Scholar
Pancreatic tumour markers | Download Table
CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial - The Lancet Oncology